on Lonza Group AG (isin : CH0013841017)
Lonza Group H1 2024 Performance on Track: Sales Increase 1.8% CER, CORE EBITDA Margin at 29.2%
Lonza Group AG announced its half-year results for 2024, showing promising signs towards meeting its full-year outlook. The company reported sales of CHF 3.1 billion, representing a growth of 1.8% at Constant Exchange Rate (CER). CORE EBITDA was recorded at CHF 893 million, resulting in a margin of 29.2%.
The Contract Development and Manufacturing Organization (CDMO) division displayed robust performance despite challenges faced in the Capsules & Health Ingredients (CHI) segment. Free cash flow remained solid at CHF 296 million.
The company confirmed its outlook for 2024 with flat CER sales growth and a high twenties CORE EBITDA margin. Additionally, Lonza upheld its upgraded Mid-Term Guidance for 2024-2028 announced in March.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Lonza Group AG news